FDA approves first brain stimulation device for home depression treatment. Flow Neuroscience's FL-100 headset uses electrical ...

Months after UW Medicine neurosurgeons implanted a first-of-its-kind brain stimulation device in a stroke patient, doctors ...

The FDA approved external trigeminal nerve stimulation (TNS) in 2019 as the first non-drug device for treating ADHD, ...

More than 20% of all patients treated with the implant had essentially no symptoms of depression after two years, researchers ...

As individuals with Alzheimer's disease (AD) move from the mild cognitive impairment stage to moderate and severe dementia, ...

In A Nutshell • A brain stimulation device cleared by the FDA in 2019 failed to beat placebo in a rigorous 150-participant ...

While proven a safe method, external trigeminal nerve stimulation was nonsuperior to sham treatment as early as 4 weeks and as long as 6 months in children and adolescents with ADHD, according to data ...

In 2019, the FDA cleared an external trigeminal nerve stimulation (eTNS) device to treat ADHD symptoms in children ages 7-12 years. In contrast to earlier findings, a new trial in England suggested ...

A large multicenter clinical trial led by King's College London with 150 children and adolescents has shown that a device ...

A larger trial of trigeminal nerve stimulation in children with ADHD produce results that differ from an earlier pilot study, raising new questions about its efficacy.

I spoke with neuroscientists from an Incheon, Korea-based startup that's looking to minimize the symptoms of epilepsy or Parkinson's disease.

When treatments such as medication and therapy aren’t able to relieve the symptoms of depression or another mental health condition, there are other options available. A psychiatrist might suggest ...